Serum IL-21 Levels in Patients With Pemphigus Vulgaris
NCT03177213 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2017-06-06
Summary
Pemphigus is severe antigen derived autoimmune bullous skin disorder, the word pemphigus is derived from the Greek word" pemphix " which means blister . Two main clinical variants are known pemphigus vulgaris (PV), and pemphigu foliaceus (PF). (Zenzo .et al., 2015).
Conditions
- Pemphigus Vulgaris
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-30
- Primary Completion
- 2018-09-30
- Completion
- 2018-12-31
More Related Trials
-
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT03272958 ·Status: COMPLETED
-
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
NCT04356014 ·Status: UNKNOWN
-
Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.
NCT07188402 ·Status: COMPLETED
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Trichoscopy in Diagnosis of Immunobollous Diseases
NCT03478072 ·Status: UNKNOWN
-
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
NCT05284929 ·Status: UNKNOWN
-
Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
NCT03636763 ·Status: UNKNOWN
-
Coagulation Activation in Patients With Pemphigus
NCT06285435 ·Status: NOT_YET_RECRUITING
-
Cellular and Molecular Biomarkers in Patients With Lichen Planus
NCT06451744 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus.
NCT07151014 ·Status: NOT_YET_RECRUITING
-
Xeroderma Pigmentosum Patient Experiences
NCT01123694 ·Status: UNKNOWN
-
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
NCT01313923 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Questionnaire and Laboratory Data on Vitiligo Vulgaris
NCT01206374 ·Status: COMPLETED
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627 ·Status: RECRUITING
-
Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum
NCT03636737 ·Status: UNKNOWN
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors
NCT04469582 ·Status: UNKNOWN
-
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT04901325 ·Status: COMPLETED ·Phase: PHASE2
-
Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients
NCT02833909 ·Status: COMPLETED ·Phase: NA
-
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
NCT01778569 ·Status: COMPLETED
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Assessment Of Serum And Tissue Levels Of Cold-Inducible RNA-Binding Protein In Patients With Lichen Planus
NCT06260189 ·Status: RECRUITING
-
Clinical and Biological Characteristics of Hidradenitis Suppurativa
NCT03967600 ·Status: RECRUITING
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA